| 4.84 1.11 (29.76%) | 07-31 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 5.95 |
1-year : | 6.95 |
| Resists | First : | 5.09 |
Second : | 5.95 |
| Pivot price | 4.14 |
|||
| Supports | First : | 4.12 |
Second : | 3.52 |
| MAs | MA(5) : | 3.9 |
MA(20) : | 4.25 |
| MA(100) : | 5.91  |
MA(250) : | 6.01 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 36.8 |
D(3) : | 18.7 |
| RSI | RSI(14): 60 |
|||
| 52-week | High : | 10.47 | Low : | 3.52 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ SCYX ] has closed below upper band by 11.8%. Bollinger Bands are 2.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.95 - 4.98 | 4.98 - 5 |
| Low: | 3.56 - 3.58 | 3.58 - 3.59 |
| Close: | 4.78 - 4.82 | 4.82 - 4.86 |
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
Thu, 30 Jul 2026
SCYNEXIS Inc (SCYX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Wed, 29 Jul 2026
SCYX|SCYNEXIS Inc|Price:3.770|Chg%:+0.140 - TradingKey
Mon, 27 Jul 2026
SCYNEXIS Inc (SCYX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sat, 25 Jul 2026
SCYNEXIS, Inc. Revenue Breakdown – NASDAQ:SCYX - TradingView
Mon, 20 Jul 2026
Federated Hermes (SCYX) group discloses 4.03% Scynexis stake in amended 13G - Stock Titan
Wed, 08 Jul 2026
Federated Hermes (SCYX) files 13G/A showing 55,207 shares (4.45%) - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Pharmaceuticals
|
|
| Shares Out | 10 (M) |
| Shares Float | 8 (M) |
| Held by Insiders | 2 (%) |
| Held by Institutions | 49.4 (%) |
| Shares Short | 348 (K) |
| Shares Short P.Month | 320 (K) |
| EPS | -3.84 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.32 |
| Profit Margin | -120.6 % |
| Operating Margin | -120 % |
| Return on Assets (ttm) | -21 % |
| Return on Equity (ttm) | -53.4 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 2.04 |
| Sales Per Share | 2.04 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -6 (M) |
| Levered Free Cash Flow | 2 (M) |
| PE Ratio | -1.26 |
| PEG Ratio | 0 |
| Price to Book value | 0.9 |
| Price to Sales | 2.35 |
| Price to Cash Flow | -8.1 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|